News & Updates

Hypertension in children and adolescents appears to be associated with heightened long-term risk of major adverse kidney events (MAKEs), according to a large retrospective study.

A short-course antibiotic treatment for children with community-acquired pneumonia (CAP) demonstrates effectiveness similar to the long-course regimen but with fewer serious adverse events (AEs), reports a study.

Treatment with either ceftazidime-avibactam (CAZ/AVI) or ceftolozane-tazobactam (C/T) is well tolerated and effective in children infected with Gram-negative pathogens resistant to carbapenems, a recent study has shown.

Influenza vaccination in pregnant women, especially during the second or third trimester, cuts the risk of infection in infants, as shown in a study.

Acute respiratory infections (ARIs) are associated with various symptoms across different age groups, according to a Korea study.

In adolescents with homozygous familial hypercholesterolemia (HoFH), treatment with inclisiran appears to be safe and efficacious for reducing low-density lipoprotein cholesterol (LDL-C) levels, according to the results of the first part of the phase III ORION-13* trial.

Exposure to biologics for inflammatory bowel disease (IBD) in utero or during breastfeeding does not appear to impair psychomotor development in infants, according to a study.

Individuals with narcolepsy, including children, appear to have an elevated risk of subclinical cardiovascular disease (CVD), according to a retrospective study.

In a scoping review examining the functional outcomes of individuals with bony sarcomas, adolescent and young adult oncology (AYAO) patients seem to fare worse than their healthy counterparts and bony sarcoma patients from various age groups.